nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—blood plasma—schizophrenia	0.0454	0.145	CbGeAlD
Amcinonide—NR3C1—urine—schizophrenia	0.0302	0.0968	CbGeAlD
Amcinonide—ANXA1—forebrain—schizophrenia	0.0249	0.0797	CbGeAlD
Amcinonide—ANXA1—telencephalon—schizophrenia	0.0229	0.0733	CbGeAlD
Amcinonide—ANXA1—gonad—schizophrenia	0.0191	0.0612	CbGeAlD
Amcinonide—ANXA1—blood—schizophrenia	0.0166	0.0533	CbGeAlD
Amcinonide—ANXA1—midbrain—schizophrenia	0.0164	0.0526	CbGeAlD
Amcinonide—NR3C1—blood plasma—schizophrenia	0.0158	0.0505	CbGeAlD
Amcinonide—ANXA1—endocrine gland—schizophrenia	0.0144	0.0462	CbGeAlD
Amcinonide—ANXA1—nervous system—schizophrenia	0.0135	0.0433	CbGeAlD
Amcinonide—ANXA1—central nervous system—schizophrenia	0.013	0.0416	CbGeAlD
Amcinonide—ANXA1—cerebellum—schizophrenia	0.0127	0.0407	CbGeAlD
Amcinonide—ANXA1—brain—schizophrenia	0.0103	0.0331	CbGeAlD
Amcinonide—NR3C1—forebrain—schizophrenia	0.00864	0.0277	CbGeAlD
Amcinonide—NR3C1—telencephalon—schizophrenia	0.00794	0.0255	CbGeAlD
Amcinonide—NR3C1—gonad—schizophrenia	0.00663	0.0212	CbGeAlD
Amcinonide—NR3C1—blood—schizophrenia	0.00578	0.0185	CbGeAlD
Amcinonide—NR3C1—midbrain—schizophrenia	0.0057	0.0183	CbGeAlD
Amcinonide—Fluocinolone Acetonide—PLA2G4A—schizophrenia	0.00565	0.306	CrCbGaD
Amcinonide—NR3C1—endocrine gland—schizophrenia	0.00501	0.0161	CbGeAlD
Amcinonide—NR3C1—nervous system—schizophrenia	0.00469	0.015	CbGeAlD
Amcinonide—NR3C1—central nervous system—schizophrenia	0.00452	0.0145	CbGeAlD
Amcinonide—NR3C1—cerebellum—schizophrenia	0.00441	0.0141	CbGeAlD
Amcinonide—Fluticasone Propionate—PLA2G4A—schizophrenia	0.00386	0.209	CrCbGaD
Amcinonide—NR3C1—brain—schizophrenia	0.00358	0.0115	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—HTR1B—schizophrenia	0.00325	0.00485	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	0.00324	0.00484	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GRM3—schizophrenia	0.00318	0.00476	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—HTR1A—schizophrenia	0.00313	0.00467	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR6—schizophrenia	0.00313	0.00467	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.00308	0.0046	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00296	0.00441	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—DRD3—schizophrenia	0.00293	0.00437	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR3A—schizophrenia	0.00289	0.00431	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00287	0.00428	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—DRD4—schizophrenia	0.00284	0.00424	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CYP26B1—schizophrenia	0.00284	0.00424	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—schizophrenia	0.00276	0.00413	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CHRM1—schizophrenia	0.00276	0.00412	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CNR1—schizophrenia	0.00271	0.00405	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00268	0.004	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DGKI—schizophrenia	0.00265	0.00395	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—DRD2—schizophrenia	0.00265	0.00395	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.00259	0.00387	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00258	0.00386	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00258	0.00386	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—FOS—schizophrenia	0.00257	0.00384	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GRM5—schizophrenia	0.00257	0.00383	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.00255	0.0038	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00249	0.00371	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.00247	0.00369	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00245	0.00366	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DGKI—schizophrenia	0.0024	0.00359	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.0024	0.00359	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.0024	0.00359	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCK—schizophrenia	0.00235	0.00351	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ESR1—schizophrenia	0.00234	0.0035	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00233	0.00347	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00226	0.00337	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCKAR—schizophrenia	0.00225	0.00336	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TH—schizophrenia	0.00224	0.00335	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—ESR1—schizophrenia	0.00223	0.00333	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—schizophrenia	0.00223	0.00333	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2A—schizophrenia	0.00222	0.00332	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—schizophrenia	0.00221	0.0033	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP1R1B—schizophrenia	0.0022	0.00328	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TPH1—schizophrenia	0.00219	0.00327	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—schizophrenia	0.00219	0.00327	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—ADORA2A—schizophrenia	0.00218	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00216	0.00322	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM2—schizophrenia	0.00212	0.00316	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—TAAR6—schizophrenia	0.00212	0.00316	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.0021	0.00314	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.0021	0.00314	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—MEF2C—schizophrenia	0.00206	0.00307	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—schizophrenia	0.00206	0.00307	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—FZD3—schizophrenia	0.00204	0.00305	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—NPY—schizophrenia	0.00204	0.00305	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00199	0.00297	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—OXT—schizophrenia	0.00197	0.00294	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1B—schizophrenia	0.00197	0.00294	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NGEF—schizophrenia	0.00196	0.00292	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.00194	0.0029	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—TAAR6—schizophrenia	0.00192	0.00287	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP3CC—schizophrenia	0.00192	0.00287	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM2—schizophrenia	0.00192	0.00287	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NTS—schizophrenia	0.00191	0.00286	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—schizophrenia	0.00191	0.00285	CbGpPWpGaD
Amcinonide—Fluoxymesterone—ESR1—schizophrenia	0.0019	0.103	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1A—schizophrenia	0.00189	0.00283	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—NPS—schizophrenia	0.00186	0.00279	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—schizophrenia	0.00183	0.00274	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2C—schizophrenia	0.00183	0.00273	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD1—schizophrenia	0.00183	0.00273	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.00182	0.00272	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM3—schizophrenia	0.0018	0.00269	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—RGS4—schizophrenia	0.0018	0.00269	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NGEF—schizophrenia	0.00178	0.00266	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD3—schizophrenia	0.00177	0.00265	CbGpPWpGaD
Amcinonide—Clobetasol propionate—CYP1A2—schizophrenia	0.00177	0.0957	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR6—schizophrenia	0.00177	0.00264	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—schizophrenia	0.00176	0.00264	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL10—schizophrenia	0.00174	0.0026	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NTS—schizophrenia	0.00174	0.0026	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD4—schizophrenia	0.00172	0.00257	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.00172	0.00256	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—schizophrenia	0.00167	0.0025	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.00166	0.00248	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CNR1—schizophrenia	0.00164	0.00245	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RGS4—schizophrenia	0.00163	0.00244	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM3—schizophrenia	0.00163	0.00244	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR6—schizophrenia	0.0016	0.0024	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—DRD2—schizophrenia	0.0016	0.00239	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR7—schizophrenia	0.0016	0.00239	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.00157	0.00234	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CHRM1—schizophrenia	0.00156	0.00233	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—schizophrenia	0.00155	0.00232	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—schizophrenia	0.00155	0.00232	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL3RA—schizophrenia	0.00152	0.00227	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—schizophrenia	0.00151	0.00225	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.00147	0.0022	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRM5—schizophrenia	0.00145	0.00217	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00142	0.00213	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DGKI—schizophrenia	0.00142	0.00212	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CHRM1—schizophrenia	0.00142	0.00212	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.0014	0.00209	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—schizophrenia	0.00138	0.00207	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL3RA—schizophrenia	0.00138	0.00206	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.00137	0.00205	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—ESR1—schizophrenia	0.00137	0.00205	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—schizophrenia	0.00136	0.00203	CbGpPWpGaD
Amcinonide—Ciclesonide—CYP2D6—schizophrenia	0.00133	0.0718	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCK—schizophrenia	0.00133	0.00198	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.00132	0.00198	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.00132	0.00198	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM5—schizophrenia	0.00132	0.00197	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP1R1B—schizophrenia	0.0013	0.00194	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PDE4B—schizophrenia	0.00129	0.00193	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00129	0.00193	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCKAR—schizophrenia	0.00127	0.0019	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—FOS—schizophrenia	0.00123	0.00184	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADORA2A—schizophrenia	0.00123	0.00184	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NR4A2—schizophrenia	0.00122	0.00182	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—schizophrenia	0.00122	0.00182	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—schizophrenia	0.00122	0.00182	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FZD3—schizophrenia	0.00121	0.0018	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCK—schizophrenia	0.0012	0.0018	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TH—schizophrenia	0.00118	0.00176	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PDE4B—schizophrenia	0.00117	0.00175	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	0.00116	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCKAR—schizophrenia	0.00115	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NPY—schizophrenia	0.00115	0.00172	CbGpPWpGaD
Amcinonide—Fluticasone furoate—ABCB1—schizophrenia	0.00114	0.0617	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—PPP3CC—schizophrenia	0.00114	0.0017	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TAAR6—schizophrenia	0.00114	0.0017	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FES—schizophrenia	0.00114	0.0017	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM2—schizophrenia	0.00114	0.0017	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2A—schizophrenia	0.00112	0.00168	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADORA2A—schizophrenia	0.00112	0.00167	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1B—schizophrenia	0.00111	0.00166	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—OXT—schizophrenia	0.00111	0.00166	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—schizophrenia	0.0011	0.00164	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—schizophrenia	0.00109	0.00164	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—schizophrenia	0.00109	0.00162	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1A—schizophrenia	0.00107	0.0016	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NPS—schizophrenia	0.00105	0.00157	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NGEF—schizophrenia	0.00105	0.00157	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NPY—schizophrenia	0.00105	0.00156	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—MEF2C—schizophrenia	0.00103	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2C—schizophrenia	0.00103	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD1—schizophrenia	0.00103	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTS—schizophrenia	0.00103	0.00153	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TSNAX—schizophrenia	0.00102	0.00153	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—EP300—schizophrenia	0.00102	0.00153	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1B—schizophrenia	0.00101	0.00151	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OXT—schizophrenia	0.00101	0.00151	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD3—schizophrenia	0.001	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.001	0.00149	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.000997	0.00149	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—EP300—schizophrenia	0.000991	0.00148	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1A—schizophrenia	0.000972	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD4—schizophrenia	0.000972	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RGS4—schizophrenia	0.000965	0.00144	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM3—schizophrenia	0.000965	0.00144	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RTN4—schizophrenia	0.000965	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.000962	0.00144	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NPS—schizophrenia	0.000957	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR6—schizophrenia	0.000947	0.00142	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	0.00094	0.0014	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD1—schizophrenia	0.000938	0.0014	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2C—schizophrenia	0.000938	0.0014	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CNR1—schizophrenia	0.000928	0.00139	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—schizophrenia	0.000918	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAG—schizophrenia	0.000915	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD3—schizophrenia	0.000909	0.00136	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR7—schizophrenia	0.000905	0.00135	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—DRD2—schizophrenia	0.000905	0.00135	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.000893	0.00133	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD4—schizophrenia	0.000882	0.00132	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.000863	0.00129	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.000845	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CNR1—schizophrenia	0.000842	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CHRM1—schizophrenia	0.000837	0.00125	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—LSM1—schizophrenia	0.000833	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	0.000829	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR7—schizophrenia	0.000822	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—DRD2—schizophrenia	0.000822	0.00123	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—EP300—schizophrenia	0.000817	0.00122	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL3RA—schizophrenia	0.000816	0.00122	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.000813	0.00121	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRG3—schizophrenia	0.000796	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TLE1—schizophrenia	0.000796	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GFAP—schizophrenia	0.000787	0.00118	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM5—schizophrenia	0.000778	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TLE3—schizophrenia	0.000753	0.00113	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—schizophrenia	0.000727	0.00109	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—schizophrenia	0.00072	0.00108	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—schizophrenia	0.000716	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCK—schizophrenia	0.000712	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	0.0007	0.00105	CbGpPWpGaD
Amcinonide—Prednisone—ABCB1—schizophrenia	0.000695	0.0376	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—PDE4B—schizophrenia	0.000693	0.00104	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCKAR—schizophrenia	0.000682	0.00102	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADORA2A—schizophrenia	0.000662	0.000988	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PLA2G4A—schizophrenia	0.00065	0.000972	CbGpPWpGaD
Amcinonide—Prednisolone—ABCB1—schizophrenia	0.000641	0.0347	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—FGA—schizophrenia	0.000634	0.000947	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2A—schizophrenia	0.000634	0.000947	CbGpPWpGaD
Amcinonide—Betamethasone—ABCB1—schizophrenia	0.000628	0.0339	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH4—schizophrenia	0.000624	0.000932	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ATP2A2—schizophrenia	0.000618	0.000923	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NPY—schizophrenia	0.000618	0.000923	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH4—schizophrenia	0.000618	0.000923	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—OXT—schizophrenia	0.000596	0.000891	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1B—schizophrenia	0.000596	0.000891	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NR4A2—schizophrenia	0.000587	0.000877	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—schizophrenia	0.000585	0.000874	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2A—schizophrenia	0.000576	0.00086	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1A—schizophrenia	0.000574	0.000857	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NPS—schizophrenia	0.000565	0.000844	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2C—schizophrenia	0.000554	0.000828	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD1—schizophrenia	0.000554	0.000828	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK2—schizophrenia	0.000539	0.000806	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD3—schizophrenia	0.000537	0.000802	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SMG6—schizophrenia	0.000537	0.000802	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD4—schizophrenia	0.000521	0.000779	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—schizophrenia	0.000515	0.00077	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2D6—schizophrenia	0.000511	0.0277	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CNR1—schizophrenia	0.000498	0.000743	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR7—schizophrenia	0.000486	0.000725	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DRD2—schizophrenia	0.000486	0.000725	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.000482	0.000719	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRL—schizophrenia	0.000459	0.000685	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—schizophrenia	0.00044	0.000657	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—schizophrenia	0.000435	0.00065	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—EP300—schizophrenia	0.000431	0.000643	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—S100B—schizophrenia	0.000427	0.000638	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB4—schizophrenia	0.000409	0.000611	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—schizophrenia	0.000404	0.000604	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLA2G4A—schizophrenia	0.000384	0.000574	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRG1—schizophrenia	0.000377	0.000563	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MEF2C—schizophrenia	0.000374	0.000558	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCB1—schizophrenia	0.000365	0.0197	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—YWHAZ—schizophrenia	0.000361	0.00054	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB3—schizophrenia	0.000353	0.000528	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—schizophrenia	0.000349	0.000522	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2A—schizophrenia	0.00034	0.000508	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—schizophrenia	0.000316	0.000472	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOA1—schizophrenia	0.000313	0.000467	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—schizophrenia	0.000305	0.000455	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—schizophrenia	0.000302	0.000451	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH4—schizophrenia	0.0003	0.000449	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GSK3B—schizophrenia	0.000274	0.000409	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT1—schizophrenia	0.000269	0.000403	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA8—schizophrenia	0.000266	0.000397	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA1A—schizophrenia	0.000242	0.000361	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—schizophrenia	0.000203	0.000303	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—schizophrenia	0.000184	0.000275	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EP300—schizophrenia	0.00018	0.000269	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—YWHAZ—schizophrenia	0.000176	0.000262	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—schizophrenia	0.000147	0.000219	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—schizophrenia	0.000129	0.000193	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—schizophrenia	0.000109	0.000163	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—schizophrenia	5.29e-05	7.91e-05	CbGpPWpGaD
